Generative AI In Medicine Global Market Report 2025

Description

Generative artificial intelligence (AI) in medicine involves using AI systems to create new data, models, or insights to advance healthcare and medical research. Its goal is to enhance diagnosis, treatment, and overall patient care by leveraging data-driven insights and innovative solutions.

Key components of generative AI in medicine include solutions and services. In this context, solutions refer to the advanced technologies and tools designed to improve healthcare delivery and outcomes. These solutions cover a broad range of applications, such as AI-driven diagnostic tools, virtual nursing assistants, and platforms for medical imaging analysis. Key functions include virtual nursing assistants, robot-assisted AI surgery, administrative process optimization, and medical imaging analysis. Applications span medical imaging, drug discovery, medical diagnosis, patient data analysis, and more. These technologies are utilized by various end-users, including hospitals and clinics, clinical research organizations, healthcare organizations, diagnostic centers, and others.

The generative artificial intelligence (AI) in medicine market research report is one of a series of new reports from The Business Research Company that provides generative artificial intelligence (AI) in medicine market statistics, including generative artificial intelligence (AI) in medicine industry global market size, regional shares, competitors with a generative artificial intelligence (AI) in medicine market share, detailed generative artificial intelligence (AI) in medicine market segments, market trends and opportunities, and any further data you may need to thrive in the generative artificial intelligence (AI) in medicine industry. This generative artificial intelligence (AI) in medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The generative AI in medicine market size has grown exponentially in recent years. It will grow from $0.66 $ billion in 2024 to $0.95 $ billion in 2025 at a compound annual growth rate (CAGR) of 43.9%. The growth in the historic period can be attributed to a rise in computational power and machine learning algorithms, growth in precision medicine, increasing demand for drug discovery, rise in adoption of AI for diagnostic imaging, and growth in investment in AI research and development.

The generative AI in medicine market size is expected to see exponential growth in the next few years. It will grow to $4.02 $ billion in 2029 at a compound annual growth rate (CAGR) of 43.5%. The growth in the forecast period can be attributed to the increasing availability of high-quality medical data, growing focus on preventive healthcare, growing need for efficient clinical trials, increasing demand for AI-enhanced patient engagement tools, and rising use of AI for drug repurposing. Major trends in the forecast period include technological advancements, telemedicine, personalized medicine, predictive analytics, and wearable health technology.

The growth of the generative artificial intelligence (AI) in medicine market is expected to be driven by the increase in digital health records. Digital health records, or electronic health records (EHRs), are systematic collections of patient health information stored electronically, which facilitate sharing across healthcare settings and enhance the efficiency and quality of patient care. This surge in digital health records is fueled by improvements in patient care, greater efficiency in healthcare delivery, regulatory support and incentives, technological advancements, and enhanced patient engagement and empowerment. AI in medicine enhances digital health records by automating documentation, organizing data, providing predictive insights, and generating personalized summaries to improve accuracy, accessibility, and overall patient care. For example, in July 2024, the European Commission reported that access to electronic health records increased to 79% in 2024 from 72% in 2023. Thus, the rise in digital health records is significantly driving the growth of the generative AI in medicine market.

Leading companies in this market are concentrating on developing innovative technologies, such as AI solutions for brain health and wellness, to advance cognitive assessment, improve patient care, and enhance mental health management. AI solutions for brain health and wellness are advanced technologies designed to assess, monitor, and improve cognitive function and mental well-being. For instance, in February 2024, DiagnaMed Holdings Corp., a Canada-based company specializing in AI-powered digital therapeutics, launched CERVAI, the first AI solution for human mental health and wellness. This solution utilizes advanced AI to comprehensively evaluate cognitive function and brain wellness. It features cutting-edge algorithms that analyze various data inputs, including cognitive tests and brain imaging, to provide accurate insights into mental health conditions. The tool offers personalized assessments and actionable recommendations, facilitating early detection of cognitive issues and tailored interventions.

In March 2022, Microsoft Corporation, a US-based technology company, acquired Nuance Communications Inc. for an undisclosed amount. This acquisition aims to enhance Microsoft's AI-driven, cloud-based solutions across various industries, improving customer experiences and productivity through advanced conversational AI and ambient intelligence. Nuance Communications Inc., a US-based software technology corporation, focuses on integrating generative AI into the healthcare sector.

Major companies operating in the Generative AI in medicine market are Microsoft Corporation, Intel Corporation, International Business Machines Corporation, NVIDIA Corporation, Philips Healthcare, Veeva Systems Inc., Nuance Communications Inc., Babylon Health Ltd., Tempus Labs Inc., DeepMind Technologies Limited, Owkin Inc., Viz.AI inc., Recursion Pharmaceuticals Inc., Caresyntax Inc., Relay Therapeutics Inc., Exscientia plc, Paige AI inc., BenevolentAI Limited, Atomwise Inc., Healx Ltd., Zebra Medical Vision Ltd., Eyenuk Inc., Syntegra Ltd., Arterys Inc.

North America was the largest region in the generative artificial intelligence (AI) in medicine market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the Generative AI in medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the Generative AI in medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The generative artificial intelligence (AI) in medicine market consists of revenues earned by entities providing services such as drug discovery and development, clinical trials, diagnostics, and virtual health assistants. The market value includes the value of related goods sold by the service provider or included within the service offering. The generative artificial intelligence (AI) in medicine market also includes medical imaging analysis tools, drug discovery platforms, clinical decision support systems, patient data synthesis solutions, administrative automation software, and precision medicine applications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Generative AI In Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on generative ai in medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generative ai in medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The generative ai in medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Component: Solutions; Service
2) By Function: Virtual Nursing Assistants; Robot-Assisted AI Surgery; Administrative Process Optimization; Medical Imaging Analysis
3) By Application: Medical Imaging; Drug Discovery; Medical Diagnosis; Patient Data Analysis; Other Applications
4) By End-User: Hospitals And Clinics; Clinical Research; Healthcare Organizations; Diagnostic Centers; Other End-Users
Subsegments:
1) By Solutions: Diagnostic Tools; Treatment Planning Systems; Personalized Medicine Platforms; Drug Discovery And Development Solutions; Medical Imaging And Analysis Software; Electronic Health Record (EHR) Enhancement Tools
2) By Services: Consulting Services; Implementation And Integration Services; Training And Education Services; Technical Support And Maintenance; Research And Development Services.
Companies Mentioned: Microsoft Corporation; Intel Corporation; International Business Machines Corporation; NVIDIA Corporation; Philips Healthcare
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r31892

1. Executive Summary

2. Generative AI In Medicine Market Characteristics

3. Generative AI In Medicine Market Trends And Strategies

4. Generative AI In Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Generative AI In Medicine Growth Analysis And Strategic Analysis Framework

5.1. Global Generative AI In Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Generative AI In Medicine Market Growth Rate Analysis
5.4. Global Generative AI In Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Generative AI In Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Generative AI In Medicine Total Addressable Market (TAM)

6. Generative AI In Medicine Market Segmentation

6.1. Global Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Solutions
Service
6.2. Global Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Virtual Nursing Assistants
Robot-Assisted AI Surgery
Administrative Process Optimization
Medical Imaging Analysis
6.3. Global Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medical Imaging
Drug Discovery
Medical Diagnosis
Patient Data Analysis
Other Applications
6.4. Global Generative AI In Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals and Clinics
Clinical Research
Healthcare Organizations
Diagnostic Centers
Other End-Users
6.5. Global Generative AI In Medicine Market, Sub-Segmentation Of Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Tools
Treatment Planning Systems
Personalized Medicine Platforms
Drug Discovery And Development Solutions
Medical Imaging And Analysis Software
Electronic Health Record (EHR) Enhancement Tools
6.6. Global Generative AI In Medicine Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consulting Services
Implementation And Integration Services
Training And Education Services
Technical Support And Maintenance
Research And Development Services

7. Generative AI In Medicine Market Regional And Country Analysis

7.1. Global Generative AI In Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Generative AI In Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Generative AI In Medicine Market

8.1. Asia-Pacific Generative AI In Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Generative AI In Medicine Market

9.1. China Generative AI In Medicine Market Overview
9.2. China Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Generative AI In Medicine Market

10.1. India Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Generative AI In Medicine Market

11.1. Japan Generative AI In Medicine Market Overview
11.2. Japan Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Generative AI In Medicine Market

12.1. Australia Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Generative AI In Medicine Market

13.1. Indonesia Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Generative AI In Medicine Market

14.1. South Korea Generative AI In Medicine Market Overview
14.2. South Korea Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Generative AI In Medicine Market

15.1. Western Europe Generative AI In Medicine Market Overview
15.2. Western Europe Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Generative AI In Medicine Market

16.1. UK Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Generative AI In Medicine Market

17.1. Germany Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Generative AI In Medicine Market

18.1. France Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Generative AI In Medicine Market

19.1. Italy Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Generative AI In Medicine Market

20.1. Spain Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Generative AI In Medicine Market

21.1. Eastern Europe Generative AI In Medicine Market Overview
21.2. Eastern Europe Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Generative AI In Medicine Market

22.1. Russia Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Generative AI In Medicine Market

23.1. North America Generative AI In Medicine Market Overview
23.2. North America Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Generative AI In Medicine Market

24.1. USA Generative AI In Medicine Market Overview
24.2. USA Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Generative AI In Medicine Market

25.1. Canada Generative AI In Medicine Market Overview
25.2. Canada Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Generative AI In Medicine Market

26.1. South America Generative AI In Medicine Market Overview
26.2. South America Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Generative AI In Medicine Market

27.1. Brazil Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Generative AI In Medicine Market

28.1. Middle East Generative AI In Medicine Market Overview
28.2. Middle East Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Generative AI In Medicine Market

29.1. Africa Generative AI In Medicine Market Overview
29.2. Africa Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Generative AI In Medicine Market Competitive Landscape And Company Profiles

30.1. Generative AI In Medicine Market Competitive Landscape
30.2. Generative AI In Medicine Market Company Profiles
- 30.2.1. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis

31. Generative AI In Medicine Market Other Major And Innovative Companies

31.1. Veeva Systems Inc.
31.2. Nuance Communications Inc.
31.3. Babylon Health Ltd.
31.4. Tempus Labs Inc.
31.5. DeepMind Technologies Limited
31.6. Owkin Inc.
31.7. Viz.ai Inc.
31.8. Recursion Pharmaceuticals Inc.
31.9. Caresyntax Inc.
31.10. Relay Therapeutics Inc.
31.11. Exscientia plc
31.12. Paige AI Inc.
31.13. BenevolentAI Limited
31.14. Atomwise Inc.
31.15. Healx Ltd.

32. Global Generative AI In Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Generative AI In Medicine Market

34. Recent Developments In The Generative AI In Medicine Market

35. Generative AI In Medicine Market High Potential Countries, Segments and Strategies

35.1 Generative AI In Medicine Market In 2029 - Countries Offering Most New Opportunities
35.2 Generative AI In Medicine Market In 2029 - Segments Offering Most New Opportunities
35.3 Generative AI In Medicine Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer